Publications
278
Citations
14,139
Est. group size
~40
Recurring co-author estimate
Active years
36
Publishing since 1991
Ana L. Mora's research focuses on chronic lung diseases, particularly idiopathic pulmonary fibrosis (scarring of lung tissue), pulmonary hypertension (high blood pressure in lung arteries), and how aging and immune cell function contribute to these conditions. Her work combines cell biology, single-cell genomic analysis, and studies of lung tissue samples to understand why lung cells lose normal function with age or disease, with an eye toward new therapeutic targets. She works within a sizeable research group and publishes at a steady, active pace in respiratory and aging-focused journals.
Publication output has grown over the last decade, rising from roughly 9-17 papers per year in 2017-2021 to over 30 in 2023, with continued strong output through 2025-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Publisher Correction: An international perspective on the future of systemic sclerosis research
Nature Reviews Rheumatology · 2025
- The Sound of Silence: Suppressing CBX5 Decreases Fibrosis by Inhibiting Fibroblasts
American Journal of Respiratory Cell and Molecular Biology · 2025
- An international perspective on the future of systemic sclerosis research
Nature Reviews Rheumatology · 2025
- In Vitro Culture of Primary Human Lung Fibroblasts Induces Collagen Expression and Promotes the Expansion of CTHRC1-positive Cells
2024
- Alveolar Epithelial Cell Dysfunction in Idiopathic Pulmonary Fibrosis Linked to Lipid Alterations: Therapeutic Implications
American Journal of Respiratory Cell and Molecular Biology · 2024
- Unveiling Biological Age: A New Frontier in Predicting Outcomes in Chronic Lung Disease
American Journal of Respiratory and Critical Care Medicine · 2024
- Impaired Natural Killer Cell Function in the Lungs of Patients With Idiopathic Pulmonary Fibrosis
2023
- Lungaging Score: Single Cell Transcriptomic Signatures in the Aging Lung
2023
- Spatial mapping of cellular senescence: emerging challenges and opportunities
Nature Aging · 2023
- Antiviral CD8<sup>+</sup>T-cell immune responses are impaired by cigarette smoke and in COPD
European Respiratory Journal · 2023
- Transcriptional changes of the aging lung
Aging Cell · 2023
- Intact mitochondrial function in the setting of telomere‐induced senescence
Aging Cell · 2023
- Abstract 10845: Akt-Dependent Vacuolar Protein Sorting 34 Activation Promotes Pulmonary Vascular Smooth Muscle Cell Proliferation and Survival in Pulmonary Hypertension
Circulation · 2022
- Antibiotic Administration and Outcomes in Hospitalized Covid-19 Patients
2022
- The Role of EBP50 in Regulating Endothelial-To-Mesenchymal Transition in Pulmonary Hypertension
bioRxiv (Cold Spring Harbor Laboratory) · 2022
- Cellular Senescence Network (SenNet)×15
- bioRxiv (Cold Spring Harbor Laboratory)×13
- American Journal of Respiratory Cell and Molecular Biology×12
- Circulation×7
- Aging Cell×6
- Mauricio Rojas
Medicine · The Ohio State University
- Mauricio Rojas
Medicine · The Ohio State University
- Jazmín Calyeca
Medicine · The Ohio State University
- Elizabeth A. Mickler
Medicine · Indiana University
- László Farkas
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile